14. J. Li, S. Lin, P. M. Vanhoutte, C. W. Woo, and A. Xu, «Akkermansia muciniphilaprotects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in ApoE-/– mice,» Circulation, vol. 133, no. 24, pp. 2434-2446, 2016.
15. Z. Jie, H. Xia, S. L. Zhong et al., «The gut microbiome in atherosclerotic cardiovascular disease,» Nature Communications, vol. 8, no. 1, article 845, 2017.
16. W. H. Tang, Z. Wang, D. J. Kennedy et al., «Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease,» Circulation Research, vol. 116, no. 3, pp. 448–455, 2015.
17. C. E. Cho and M. A. Caudill, «Trimethylamine-N-Oxide: Friend, Foe, or Simply Caught in the Cross-Fire?» Trends in Endocrinology and Metabolism, vol. 28, no. 2, pp. 121-130, 2017.
18. R. A. Koeth, B. S. Levison, M. K. Culley et al., «γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO,» Cell Metabolism, vol. 20, no. 5, pp. 799–812, 2014.
19. J. Chhibber-Goel, V. Singhal, N. Parakh, B. Bhargava, and A. Sharma, «The metabolite trimethylamine-N-oxide is an emergent biomarker of human health,» Current Medicinal Chemistry, vol. 24, no. 36, pp. 3942–3953, 2017.
20. W. H. Tang, Z. Wang, B. S. Levison et al., «Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk,» The New England Journal of Medicine, vol. 368, no. 17, pp. 1575–1584, 2013.
21. J. M. Brown and S. L. Hazen, «The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases,» Annual Review of Medicine, vol. 66, no. 1, pp. 343–359, 2015.
22. R. A. Koeth, Z. Wang, B. S. Levison et al., «Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis,» Nature Medicine, vol. 19, no. 5, pp. 576–585, 2013.
23. W. Zhu, J. C. Gregory, E. Org et al., «Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk,» Cell, vol. 165, no. 1, pp. 111–124, 2016.
24. K. A. Romano, E. I. Vivas, D. Amador-Noguez, and F. E. Rey, «Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide,» mBio, vol. 6, no. 2, article e02481, 2015.
25. B. J. Bennett, T. Q. A. Vallim, Z. Wang et al., «Trimethylamine-n-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation,» Cell Metabolism, vol. 17, no. 1, pp. 49–60, 2013.
